INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹47 Cr | ₹114 Cr | ₹-430 Cr | ₹370 Cr | ₹16 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDEGENE ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹114 Cr |
| Mar2023 | ₹-430 Cr |
| Mar2022 | ₹370 Cr |
| Mar2021 | ₹16 Cr |
How is Net Cash Inflow / Outflow of INDEGENE Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹47 Cr | -59.14 | |
| Mar2024 | ₹114 Cr | Positive | |
| Mar2023 | ₹-430 Cr | Negative | |
| Mar2022 | ₹370 Cr | 2,174.92 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹12,020.2 Cr | 3.1% | 6.5% | -11.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 3.1% |
6.5% |
-11.3% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses